📰 Nasdaq Prok News
Nasdaq Prok News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Nasdaq Prok. Real-time updates on events, politics, business and more.
April 26, 2024
ProKidney Corp. (NASDAQ:PROK – Get Free Report) SVP Darin J. Weber sold 16,438 shares of the stock in a transaction dated Monday, April 22nd. The shares were sold at an average price of $2.51, for a total value of $41,259.38. Following the completion of the transaction, the senior vice president now owns 155,194 shares of […]
February 22, 2024
ProKidney (NASDAQ:PROK – Get Free Report) and Cabaletta Bio (NASDAQ:CABA – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, institutional ownership, valuation and profitability. Volatility and Risk ProKidney has a beta of […]
January 10, 2024
Social Capital Group LLC decreased its holdings in shares of ProKidney Corp. (NASDAQ:PROK – Free Report) by 12.8% during the 3rd quarter, Holdings Channel.com reports. The fund owned 11,573,000 shares of the company’s stock after selling 1,700,000 shares during the period. ProKidney makes up approximately 89.0% of Social Capital Group LLC’s portfolio, making the stock […]
November 14, 2023
WINSTON-SALEM, N.C., Nov. 14, 2023 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (“ProKidney”), a leading late clinical-stage cellular therapeutics...
November 1, 2023
ProKidney Corp. (NASDAQ:PROK – Get Free Report) major shareholder Chamath Palihapitiya sold 92,500 shares of the company’s stock in a transaction dated Friday, October 27th. The shares were sold at an average price of $1.59, for a total value of $147,075.00. Following the completion of the sale, the insider now directly owns 7,427,000 shares of […]
September 25, 2023
ProKidney Corp. (NASDAQ:PROK – Get Free Report) fell 5% during trading on Monday . The company traded as low as $4.56 and last traded at $4.59. 103,208 shares changed hands during mid-day trading, a decline of 64% from the average session volume of 287,260 shares. The stock had previously closed at $4.83. Wall Street Analysts […]
September 22, 2023
ProKidney Corp. (NASDAQ:PROK – Get Free Report) major shareholder Chamath Palihapitiya sold 1,700,000 shares of the business’s stock in a transaction that occurred on Tuesday, September 19th. The stock was sold at an average price of $5.47, for a total value of $9,299,000.00. Following the transaction, the insider now directly owns 2,073,000 shares in the […]
September 21, 2023
ProKidney Corp. (NASDAQ:PROK – Get Free Report) major shareholder Chamath Palihapitiya sold 1,700,000 shares of the company’s stock in a transaction that occurred on Tuesday, September 19th. The stock was sold at an average price of $5.47, for a total value of $9,299,000.00. Following the transaction, the insider now directly owns 2,073,000 shares in the […]
September 14, 2023
ProKidney Corp. (NASDAQ:PROK – Get Free Report) shares were down 5.7% on Tuesday . The company traded as low as $7.81 and last traded at $7.87. Approximately 69,493 shares changed hands during mid-day trading, a decline of 73% from the average daily volume of 252,825 shares. The stock had previously closed at $8.35. Analysts Set […]
September 12, 2023
ProKidney (NASDAQ:PROK – Get Free Report) and Coeptis Therapeutics (NASDAQ:COEP – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, profitability, earnings, analyst recommendations, institutional ownership, dividends and valuation. Analyst Recommendations This is a summary of current […]